ClassID:

21172

A61K2039/525 - page 3 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA Virus

Recent Application in this class:
#601
20060153874
2006-07-13

Recombinant poxvirus comprising at least two compox ATI promoters

#602
20060153871
2006-07-13

H3 equine influenza A virus

#603
20060147467
2006-07-06

Materials and methods for immunizing against FIV infection

#604
20060147464
2006-07-06

Chicken astrovirus type 2

#605
20060143719
2006-06-29

Use of golden hamster as infectivity model of SARS

#606
20060141566
2006-06-29

Virus preparations and methods

#607
20060141509
2006-06-29

Recovery of virus from cell culture using a hypertonic salt solution

#608
20060134138
2006-06-22

System producing infectious recombinant influenza virus

#609
20060134065
2006-06-22

Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use

#610
20060121048
2006-06-08

Genetically engineered cell lines and systems for propagating virus and methods of use thereof

#611
20060110740
2006-05-25

Use of sendai virus as a human parainfluenza vaccine

#612
20060094030
2006-05-04

Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics

#613
20060093620
2006-05-04

Modified poxviruses, including modified smallpox virus vaccine based on recombinant drug-sensitive vaccinia virus, and new selection methods

#614
20060083756
2006-04-20

Circovirus sequences associated with piglet weight loss disease (PWD)

#615
20060057162
2006-03-16

Induction of cytotoxic T-lymphocyte responses

#616
20060057116
2006-03-16

Recombinant influenza viruses for vaccines and gene therapy

#617
20060051368
2006-03-09

Herpes simplex virus mutations

#618
20060039928
2006-02-23

Isolated avian cell that expresses Vaccinia virus host range genes

#619
20060029617
2006-02-09

Porcine circovirus and Helicobacter combination vaccines and methods of use

#620
20060024668
2006-02-02

Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics

#621
20060014148
2006-01-19

Igg fc/hiv-gp120/c3d fusion protien

#622
20060002958
2006-01-05

Attenuation of metapneumovirus

#623
20050287129
2005-12-29

Vectors and methods for long-term immune evasion to prolong transplant viability

#624
20050271684
2005-12-08

Apparatus and method for transdermal delivery of multiple vaccines

#625
20050239187
2005-10-27

Methods to culture circovirus

#626
20050239052
2005-10-27

Cloning of rhadinovirus genome and methods for its use

#627
20050227224
2005-10-13

Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions

#628
20050226889
2005-10-13

Inhibition of viral infection and spread with viral and RhoA-derived peptides

#629
20050220807
2005-10-06

Methods of delivery of exogenous proteins to the cytosol and uses thereof

#630
20050186575
2005-08-25

Corona-virus-like particles comprising functionally deleted genomes

#631
20050186225
2005-08-25

Adenovirus formulations

#632
20050181495
2005-08-18

Large scale productions of virus antigen

#633
20050181458
2005-08-18

HPV CD8+ T-cell epitopes

#634
20050181359
2005-08-18

Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content

#635
20050180984
2005-08-18

Methods of generating a humoral immune response against human immunodeficiency virus (HIV) comprising administering Nef apoptotic motif-containing polypeptide-conjugates

#636
20050169939
2005-08-04

Chicken anemia virus vaccine from cell line

#637
20050163758
2005-07-28

Cell-specific and/or tumor-specific promoter retargeting of herpes γ 34.5 gene expression

#638
20050159385
2005-07-21

JAK/STAT inhibitors and MAPK/ERK inhibitors for RSV infection

#639
20050158278
2005-07-21

Means and methods for the production of adenovirus vectors

#640
20050152920
2005-07-14

Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof

#641
20050142115
2005-06-30

Papilloma pseudovirus and preparation

#642
20050129712
2005-06-16

Combined dna/protein vaccine compositions

#643
20050123564
2005-06-09

Production of viruses viral isolates and vaccines

#644
20050119472
2005-06-02

GB virus C and methods of treating viral infections

#645
20050119471
2005-06-02

Sequence analysis of the tetravalent rotavirus vaccine

#646
20050119165
2005-06-02

Vascular endothelial growth factor dimers

#647
20050118698
2005-06-02

Multiplication of viruses in a cell culture

#648
20050096282
2005-05-05

Adeno-associated virus-delivered ribozyme compositions and methods for the treatment of retinal diseases

#649
20050089531
2005-04-28

Recombinant feline herpesvirus type 1 and polyvalent vaccine using the same

#650
20050084497
2005-04-21

Circovirus sequences associated with piglet weight loss disease (PWD)

#651
20050069866
2005-03-31

Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use

#652
20050058655
2005-03-17

Causative agent of the Mystery Swine Disease, vaccine compositions and diagnostic kits

#653
20050054846
2005-03-10

Method for generating influenza viruses and vaccines

#654
20050054074
2005-03-10

Methods and interferon deficient substrates for the propagation of viruses

#655
20050053616
2005-03-10

HIV-1 peptide, antigen, immunogenic composition, diagnostic method and immunoassay kit

#656
20050048467
2005-03-03

Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN

#657
20050048082
2005-03-03

Adjuvant viral particle

#658
20050048073
2005-03-03

Methods of determining west nile virus epitopes and method of using the same

#659
20050037487
2005-02-17

Recombinant influenza vectors with a polII promoter and ribozymes for vaccines and gene therapy

#660
20050031639
2005-02-10

Materials and methods for immunizing against FIV infection

#661
20050028226
2005-02-03

Vaccinia virus MVA-E3L-knockout-mutants and use thereof

#662
20050019349
2005-01-27

Poxvirus containing formulations and process for preparing stable poxvirus containing compositions

#663
20050019347
2005-01-27

Recombinant mva capable of expressing structural hcv antigens

#664
20050019344
2005-01-27

Human cytomegalovirus (HCMV) cytotoxic T cell epitopes, polyepitopes compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor

#665
20050008651
2005-01-13

Circovirus sequences associated with piglet weight loss disease (PWD)

#666
14309548
2016-10-25

African swine fever virus georgia strain adapted to efficiently grow in the vero cell line